ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,350,000 | -61.3% | 41,611 | -66.7% | 0.35% | -47.6% |
| Q1 2016 | $3,490,000 | +375.5% | 124,853 | +505.6% | 0.67% | +546.6% |
| Q4 2015 | $734,000 | -85.3% | 20,615 | -86.6% | 0.10% | -76.9% |
| Q1 2015 | $5,009,000 | -42.1% | 153,717 | -43.6% | 0.44% | -42.5% |
| Q4 2014 | $8,647,000 | +8.9% | 272,350 | -15.1% | 0.77% | +5.2% |
| Q3 2014 | $7,943,000 | -16.4% | 320,821 | -23.7% | 0.74% | -4.4% |
| Q2 2014 | $9,497,000 | -7.9% | 420,411 | -0.9% | 0.77% | -2.5% |
| Q1 2014 | $10,316,000 | -51.1% | 424,032 | -49.8% | 0.79% | -44.8% |
| Q4 2013 | $21,087,000 | -16.6% | 843,851 | -8.3% | 1.43% | -12.6% |
| Q3 2013 | $25,272,000 | +47.4% | 920,017 | -2.6% | 1.64% | +19.8% |
| Q2 2013 | $17,150,000 | – | 944,930 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |